The translational values of TRIM family in pan-cancers: From functions and mechanisms to clinics

Pharmacol Ther. 2021 Nov:227:107881. doi: 10.1016/j.pharmthera.2021.107881. Epub 2021 Apr 28.

Abstract

Cancer is the second leading cause of human death across the world. Tripartite motif (TRIM) family, with E3 ubiquitin ligase activities in majority of its members, is reported to be involved in multiple cellular processes and signaling pathways. TRIM proteins have critical effects in the regulation of biological behaviors of cancer cells. Here, we discussed the current understanding of the molecular mechanism of TRIM proteins regulation of cancer cells. We also comprehensively reviewed published studies on TRIM family members as oncogenes or tumor suppressors in the oncogenesis, development, and progression of a variety of types of human cancers. Finally, we highlighted that certain TRIM family members are potential molecular biomarkers for cancer diagnosis and prognosis, and potential therapeutic targets.

Keywords: Cancer; Diagnosis; Inhibitor; Prognosis; TRIM; Therapeutic targets.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics
  • Protein Domains* / drug effects
  • Protein Domains* / genetics
  • Protein Domains* / physiology